{
  "ticker": "TRDA",
  "company_name": "Entrada Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT07038824",
      "title": "A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Duchenne Muscular Dystrophy (DMD)",
      "start_date": "2025-08-30",
      "completion_date": "2029-03-01",
      "enrollment": 0,
      "sponsor": "Entrada Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04245917",
      "title": "Natural History Study of MNGIE",
      "status": "SUSPENDED",
      "phase": "",
      "condition": "Mitochondrial Neurogastrointestinal Encephalomyopathy",
      "start_date": "2020-08-06",
      "completion_date": "2026-02",
      "enrollment": 0,
      "sponsor": "Entrada Therapeutics, Inc."
    },
    {
      "nct_id": "NCT07037862",
      "title": "A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Duchenne Muscular Dystrophy (DMD)",
      "start_date": "2025-06-30",
      "completion_date": "2029-03-28",
      "enrollment": 0,
      "sponsor": "Entrada Therapeutics, Inc."
    }
  ],
  "summary": {
    "total_trials": 3,
    "by_phase": {
      "PHASE1, PHASE2": 2,
      "": 1
    },
    "by_status": {
      "RECRUITING": 2,
      "SUSPENDED": 1
    },
    "active_trials": 2,
    "completed_trials": 0,
    "conditions": [
      "Duchenne Muscular Dystrophy (DMD)",
      "Mitochondrial Neurogastrointestinal Encephalomyopathy"
    ],
    "lead_stage": "unknown"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:22:28.955994",
    "search_query": "Entrada Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Entrada+Therapeutics,+Inc."
  }
}